Product Images Glycopyrrolate

This is a product label for Glycopyrrolate Injection, used for Intramuscular or Intravenous Administration, manufactured by Xiromed, LLC in Florham Park, NJ. The product contains Benzyl Alcohol as a preservative and is not for use in newborns. The usual dosage is provided in the package insert, and the product should be stored at a controlled room temperature of 20° to 25°C. The package contains 25 x 1mL single-dose vials.*

This is a description of a medication called Glycopyrrolate Injection, USP, with a strength of 0.2 mg/mL. It is sold in a single-dose vial that contains Benzyl Alcohol and can be administered intramuscularly or intravenously. The manufacturer of the medication is Xiromed, LLC, located in Florham Park, NJ, and the product originates from India. The medication is prescription-only and has a National Drug Code of 70700-165-22. The label also includes a code number and additional details on how to handle and store the product.*

This product description is for a Glycopyrrolate Injection with a strength of 0.2 mg/mL, which is used for intramuscular or intravenous administration. It comes in a package of 10 x 20 mL multiple dose vials that must be stored within the temperature range of 20°C to 25°C (68°F to 77°F). The vial contains water for injection, USP g.s./benzyl alcohol, NF (preservative) 0.9%, with its pH adjusted accordingly by hydrochloric acid and/or sodium hydroxide. The product is not for use in newborns and contains benzyl alcohol. The batch details and 2D barcode are to be printed online in a specific area of the packaging of size 80x65 mm.*

This is a description of a medication called Glycopyrrolate, which is available in a 4mg/20 mL injection solution. It contains Water for Injection, USP, Glycopyrrolate, and Senzyi Alcohol, NF as preservative. The usual dosage is 0.2mg/mL as mentioned in the package insert. It is stored at a temperature range of 20° to 25°C (68° to 77°F). The medication should not be used for newborns and its administration types are through Intramuscular or Intravenous methods. The product is in a 20mL Multiple Dose Vial, and the lot number is indicated as 17x15mm.*

This appears to be a product label for Glycopyrrolate Injection, used for intravenous or intramuscular administration, except for newborns that should not use it. Each dose is contained in a 2 mL single-dose vial produced by the manufacturer of Xiromed LLC, Florham Park, NJ, USA. The product contains 0.4mg/2 mL (0.2 mg/mL) Glycopyrrolate and benzyl alcohol. No additional information is available from the scanned text.*

Glycopyrrolate Injection, USP is a medication manufactured for Xiromed, LLC in India with a code number of TS/DRUGS/2/2015. The medication is provided in a 2 mL single dose vial that contains 0.4 mg of the active ingredient, Glycopyrrolate, and is intended for intramuscular or intravenous use. The product has an NDC of 70700-166-22 for prescription use only and contains benzyl alcohol. The label indicates that it should be stored at room temperature.*

This is a medication called Glycopyrrolate Injection, which is available only with a prescription. The medication is used for intramuscular or intravenous administration, and comes in a 5mL multiple-dose vial. It is not meant to be used for newborns, and contains Benzyl Alcohol as a preservative. The usual dosage should be followed as per the package insert. The medication should be stored at a temperature between 20 to 25 degrees Celsius. The product is manufactured for a company called Xiromed LLC in Florham Park, New Jersey, and is a product of India. The LOT and EXP numbers are given, but without context. *

Not available.*